Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
…, M Vis, W Lems, AE Voskuyl, E De Groot… - Arthritis & …, 2006 - Wiley Online Library
Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
…, AV Schattenberg, M Matucci-Cerinic, AE Voskuyl… - Jama, 2014 - jamanetwork.com
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …
2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA …
…, RF Van Vollenhoven, AE Voskuyl… - Annals of the …, 2020 - ard.bmj.com
Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
ETH Molenaar, AE Voskuyl, HJ Dinant… - … : Official Journal of …, 2004 - Wiley Online Library
Objective. To assess whether radiologic progres-sion occurs during clinical remission in
patients with rheumatoid arthritis (RA). Methods. One hundred eighty-seven patients with
patients with rheumatoid arthritis (RA). Methods. One hundred eighty-seven patients with
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
MJL Peters, VP van Halm, AE Voskuyl… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular
disease (CVD), but longitudinal observations are limited and the precise magnitude is …
disease (CVD), but longitudinal observations are limited and the precise magnitude is …
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
…, MJ Coenen, MC Vonk, AE Voskuyl… - Nature …, 2010 - nature.com
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and
internal organs that leads to profound disability and premature death. To identify new SSc …
internal organs that leads to profound disability and premature death. To identify new SSc …
Polymyositis: an overdiagnosed entity
…, H Burger, WJ van Venrooij, AE Voskuyl… - Neurology, 2003 - AAN Enterprises
Background: According to widely used criteria (Bohan and Peter criteria, 1975), dermatomyositis
(DM) is differentiated from polymyositis (PM) only by skin changes. More recent criteria …
(DM) is differentiated from polymyositis (PM) only by skin changes. More recent criteria …
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
…, MA Van Leeuwen, AE Voskuyl… - … : Official Journal of …, 2010 - Wiley Online Library
Objective For patients with rheumatoid arthritis (RA), yearly influenza vaccination is recommended.
However, its efficacy in patients treated with rituximab is unknown. The objectives of …
However, its efficacy in patients treated with rituximab is unknown. The objectives of …
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
…, S Keijzer, G Vidarsson, AE Voskuyl… - The Lancet …, 2021 - thelancet.com
Background Data are scarce on immunogenicity of COVID-19 vaccines in patients with
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
[HTML][HTML] Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
…, JWR Twisk, BAC Dijkmans, AE Voskuyl - Arthritis research & …, 2006 - Springer
Rheumatoid arthritis (RA) is characterized by inflammation and an increased risk for
cardiovascular disease (CVD). This study investigates possible associations between CVD and the …
cardiovascular disease (CVD). This study investigates possible associations between CVD and the …